WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ: 330350)

Market Cap	91.89B
Revenue (ttm)	98.27B
Net Income (ttm)	7.65B
Shares Out	13.20M
EPS (ttm)	578.66
PE Ratio	12.03
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,917
Open	7,020.00
Previous Close	7,020.00
Day's Range	6,920.00 - 7,100.00
52-Week Range	6,500.00 - 13,680.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About WITHUS PHARMACEUTICAL Co.,LTD.

WITHUS PHARMACEUTICAL Co.,LTD. engages in the production and sale of pharmaceutical products in South Korea. It offers circulatory agents, endocrine cost medications, osteoporosis treatment products, antithrombotic medicines, central nervous system agents, digestive tract medications, respiratory/skin preparations, musculoskeletal medications, antibiotics, antifungal and antiviral drugs, genitourinary tract medications, psychotropic agents, and other products. The company was previously known as Withers Medipharm Co. , Ltd. and changed its name...

• Industry: Pharmaceutical Preparations
• Founded: 2004
• Employees: 121
• Stock Exchange: KOSDAQ
• Ticker Symbol: 330350

Financial Performance

In 2023, WITHUS PHARMACEUTICAL Co.,LTD.'s revenue was 80.12 billion, an increase of 23.87% compared to the previous year's 64.68 billion. Earnings were 7.96 billion, an increase of 221.04%.